Holding the Line: Inside the Ongoing Battle Between Pet Food Advocates and the FDA Over Transparency and Enforcement

By Investigative Reporting Desk
Published September 2026

Main Facts: A Relationship Strained by Silence

For years, pet owners have operated under the assumption that federal regulatory agencies are actively safeguarding the food bowls of America’s cats and dogs. However, behind the scenes, consumer advocacy organizations like TruthaboutPetFood.com paint a starkly different picture—one characterized by systemic stonewalling, unreturned inquiries, and an apparent reluctance by the U.S. Food and Drug Administration (FDA) to enforce federal labeling and safety statutes within the multi-billion-dollar commercial pet food industry.

At the center of this ongoing accountability crisis is a fundamental disagreement over what constitutes "truthful labeling" and proactive public health communication. Federal law—specifically the Federal Food, Drug, and Cosmetic Act (FD&C Act)—explicitly mandates that all animal foods, much like human foods, must be safe to consume, manufactured under sanitary conditions, devoid of harmful substances, and truthfully labeled. Yet, consumer advocates argue that these statutory obligations are frequently ignored, leaving pet owners vulnerable to misleading marketing and incomplete epidemiological data regarding emerging health threats.

From questions surrounding commercial cat food imagery to opaque definitions of slaughterhouse "tankage," critical information gaps regarding avian influenza risks, and the fallout from the agency’s fractured relationship with the Association of American Feed Control Officials (AAFCO), the FDA’s Center for Veterinary Medicine (CVM) faces mounting pressure. Despite repeated formal inquiries, petitions, and legal follow-ups, the agency’s response pattern has largely defaulted to silence, deflection, or outright refusal to act.

Chronology of Inquiries: A Timeline of Agency Non-Response

A chronological review of communications between TruthaboutPetFood.com and the FDA highlights a troubling pattern of institutional inaction spanning multiple years.

January – March 2026: The Meow Mix Label Controversy

• January 28, 2026: Advocates submitted a formal inquiry to the FDA regarding the labeling of Meow Mix Original Choice Cat Food. The product packaging prominently features appetizing imagery of a grilled piece of chicken breast, a roasted turkey medallion, and two fresh fish fillets. However, a review of the ingredient panel reveals that the food is manufactured using processed meal derivatives: chicken by-product meal, turkey by-product meal, salmon meal, and ocean fish meal. Advocates asked the agency to explain how this packaging complies with the FD&C Act’s requirement that animal foods be "truthfully labeled."
• March 12, 2026: Having received zero response from the CVM, advocates sent a follow-up email demanding either an answer to the initial query or an explanation for the agency’s refusal to engage.
• Current Status (September 15, 2026): Over seven months after the initial inquiry, the FDA has provided no explanation.

July 2026: The Mystery of Slaughterhouse "Tankage"

• July 6, 2026: Advocates pressed the FDA for clarification on ingredient identification and labeling requirements for heavily processed animal by-products. Specifically, they questioned how "tankage"—condemned animal material processed in slaughter facilities—must be disclosed to consumers on pet food packaging. For instance, advocates asked whether tankage derived from a USDA chicken slaughter facility is legally required to appear on a label simply as "chicken" or under a more accurate derivative term like "chicken meal."
• Current Status: The FDA failed to provide an answer, leaving consumers in the dark regarding the true nature of common protein sources in commercial feeds.

September 2025 – Present: Avian Influenza and Epidemiological Blind Spots

• September 15, 2025: Amid rising concerns over Highly Pathogenic Avian Influenza (HPAI), the FDA issued multiple public safety alerts warning consumers about the risks of raw pet food contamination. However, advocates pointed out a glaring statistical discrepancy: according to USDA data tracking 145 diagnosed domestic cats since May 2022, only 4% of those cats had consumed raw pet food. Advocates submitted urgent questions to the CVM: What style of food did the remaining 96% of afflicted cats consume? What percentage were strictly indoor cats, and how many had outdoor access?
• Current Status: The FDA has refused to answer these questions. Advocates argue that by hyper-focusing public warnings exclusively on raw diets while withholding comprehensive lifestyle and dietary data for the overwhelming majority of cases, the agency may be committing a form of public health negligence.

May – June 2025: The AAFCO Modernization Disconnect

• May 29, 2025: Following the FDA’s high-profile decision to end its long-standing collaborative Memorandum of Understanding (MOU) with AAFCO, advocates sought clarity regarding the future of the AAFCO Pet Food Label Modernization initiative. They asked whether pending label updates would still be recognized and implemented by federal regulators.
• June 2025: The FDA’s AskCVM department responded within a week, but merely provided a generic web link acknowledging the expired MOU—a page containing zero information about label modernization. When pressed with a direct follow-up on June 5, 2025, asking a simple "yes or no" question about whether the label changes would be implemented, the agency doubled down on its deflection, simply advising stakeholders to refer to its previous, uninformative response.

Supporting Data: The 1,333-Day Citizen Petition Delay

The friction between pet food advocates and federal regulators is not a recent development. It is rooted in deep-seated structural disagreements over statutory enforcement.

In July 2022, TruthaboutPetFood.com formally filed a comprehensive Citizen Petition with the FDA. This official administrative request implored the agency to strictly enforce existing federal laws governing misleading pet food ingredient names and marketing practices. Under standard federal administrative procedures, agencies are generally expected to provide a substantive response to citizen petitions within 180 days.

Instead, the FDA subjected the petition to bureaucratic purgatory. It took the agency a staggering 1,333 days to issue its formal determination. When the response finally arrived, the answer was a definitive "no"—the FDA formally declined to enforce the statutory requirements requested by the petitioners.

Refusing to accept a flat rejection in the face of what they view as rampant consumer deception, advocates submitted a formal Petition for Reconsideration on April 13, 2026. This follow-up filing included a substantial body of new evidence demonstrating how everyday pet owners are actively misled by unregulated pet food labeling practices. The petition requested a formal decision from the agency within 45 days.

As of mid-September 2026—155 days after the request for reconsideration was submitted—the FDA has yet to issue a response.

Official Responses and Regulatory Stonewalling

The overarching theme of the FDA’s interactions with pet food consumer advocates is characterized by institutional avoidance. While the CVM occasionally responds to routine communications—such as its brief acknowledgment of the expired AAFCO agreement—substantive answers to complex regulatory questions are virtually non-existent.

When inquiries touch upon core consumer protection issues, such as:

1. Misleading visual marketing (e.g., raw meat imagery on bags of heavily processed meal-based kibble),
2. Obscure processing definitions (e.g., how condemned slaughterhouse tankage is translated onto ingredient decks), or
3. Incomplete public health risk assessments (e.g., HPAI infection vectors in non-raw diets),

The agency’s communication channels routinely fall silent. This lack of transparency has transformed the relationship between regulators and consumer advocates from a collaborative oversight framework into an adversarial struggle for basic information.

Implications for Pet Owners and the Commercial Pet Food Industry

The implications of the FDA’s regulatory passivity extend far beyond bureaucratic friction; they directly impact millions of households and the health of companion animals nationwide.

1. Consumer Deception and Informed Choice

When pet food manufacturers are permitted to display high-end, human-grade ingredients like fresh chicken breasts, whole turkeys, and whole fish fillets on packaging that actually contains rendered by-product meals, consumers are fundamentally misled. Purchasing decisions are frequently guided by visual cues on the front of the bag rather than fine-print ingredient panels. By failing to enforce statutory requirements for "truthful labeling," the FDA effectively permits marketing practices that obscure the true quality and composition of commercial pet foods.

2. Public Health Vulnerabilities

The withholding or incomplete presentation of epidemiological data—such as the true dietary backgrounds of cats diagnosed with avian influenza—prevents pet owners from properly assessing risk. If 96% of afflicted felines consumed diets other than raw food, restricting public warnings solely to raw diets creates a dangerous false sense of security. Comprehensive, transparent reporting is essential for veterinary professionals and pet owners to implement effective preventative measures.

3. Regulatory Uncertainty Post-AAFCO

The breakdown of the historical partnership between the FDA and AAFCO has left a vacuum in pet food standardization. Without clear federal leadership on initiatives like the Pet Food Label Modernization project, the industry risks fracturing into inconsistent state-by-state standards, further confusing consumers who rely on uniform labeling guidelines.

A Pledge to Continue the Fight

Despite the daunting timeline of delays, unreturned emails, and flat rejections, consumer advocates remain resolute. Susan Thixton, founder of TruthaboutPetFood.com and the Association for Truth in Pet Food, emphasizes that the advocacy community will not back down.

"Despite FDA’s lack of responses to many issues, we WILL continue to ask them for answers," Thixton stated.

As long as regulatory oversight remains passive, independent watchdogs will continue to shine a light into the opaque corners of the pet food industry, demanding accountability from the agencies tasked with protecting our most vulnerable family members.